Cargando…

Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients

INTRODUCTION: Systemic lupus erythematosus (SLE) is characterized by early atherothrombosis. Pulse wave velocity (PWV) is a promising tool for the diagnosis of early vascular remodelling and initial atherosclerotic plaque formation. Our objective was to evaluate PWV and its relationship with coronar...

Descripción completa

Detalles Bibliográficos
Autores principales: Dziedzic-Oleksy, Hanna, Mazurek, Adam, Bugała, Kamil, Perricone, Carlo, Drabik, Leszek, Płazak, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301661/
https://www.ncbi.nlm.nih.gov/pubmed/35875719
http://dx.doi.org/10.5114/reum.2022.117836
_version_ 1784751466351689728
author Dziedzic-Oleksy, Hanna
Mazurek, Adam
Bugała, Kamil
Perricone, Carlo
Drabik, Leszek
Płazak, Wojciech
author_facet Dziedzic-Oleksy, Hanna
Mazurek, Adam
Bugała, Kamil
Perricone, Carlo
Drabik, Leszek
Płazak, Wojciech
author_sort Dziedzic-Oleksy, Hanna
collection PubMed
description INTRODUCTION: Systemic lupus erythematosus (SLE) is characterized by early atherothrombosis. Pulse wave velocity (PWV) is a promising tool for the diagnosis of early vascular remodelling and initial atherosclerotic plaque formation. Our objective was to evaluate PWV and its relationship with coronary atherosclerosis and thrombotic biomarkers in patients with SLE. MATERIAL AND METHODS: In 26 patients with SLE with stable clinical conditions, mean age of 39.1 ±11.7 years and without a history of coronary artery disease, multidetector computed tomography (MDCT)-based coronary calcium scoring (CACS) was performed and PWV measured. Laboratory evaluation included serum levels of anticardiolipin and anti-β2-glycoprotein antibodies (anti-β2-GPI), lupus anticoagulant (LA), D-dimers, thrombin–antithrombin complexes (TAT), and von Willebrand factor (vWF). RESULTS: Multidetector computed tomography revealed coronary calcifications in 8 (30.8%) patients and the median CACS was 52.4 HU (range 2–843.2). The mean PWV was 9.0 ±3.2 m/s and was higher in patients aged > 50 years (+33.7% vs. < 50 years), those with positive LA (+28.2% vs. LA negative), TAT ≥ 10 μg/l (+18.1% vs. < 10 μg/l), vWF ≥ 200 IU/dl (+51.8% vs. < 200 IU/dl) and with coronary atherosclerosis (CACS > 0; +21.4% vs. CACS = 0). In contrast, the duration of the disease, D-dimers, anticardiolipin, and anti-β2-GPI antibodies did not influence PWV. In the group without atherosclerosis (CACS = 0, n =18), patients with vWF ≥ 200 IU/dl had a 19.3% higher PWV compared to the rest. CONCLUSIONS: In patients with SLE, PWV was associated with the presence of coronary atherosclerotic lesions in MDCT. Furthermore, arterial stiffness was higher in patients with markers of endothelial dysfunction and a prothrombotic state, suggesting their contribution to the early stages of arterial remodelling in SLE.
format Online
Article
Text
id pubmed-9301661
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
record_format MEDLINE/PubMed
spelling pubmed-93016612022-07-22 Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients Dziedzic-Oleksy, Hanna Mazurek, Adam Bugała, Kamil Perricone, Carlo Drabik, Leszek Płazak, Wojciech Reumatologia Original Paper INTRODUCTION: Systemic lupus erythematosus (SLE) is characterized by early atherothrombosis. Pulse wave velocity (PWV) is a promising tool for the diagnosis of early vascular remodelling and initial atherosclerotic plaque formation. Our objective was to evaluate PWV and its relationship with coronary atherosclerosis and thrombotic biomarkers in patients with SLE. MATERIAL AND METHODS: In 26 patients with SLE with stable clinical conditions, mean age of 39.1 ±11.7 years and without a history of coronary artery disease, multidetector computed tomography (MDCT)-based coronary calcium scoring (CACS) was performed and PWV measured. Laboratory evaluation included serum levels of anticardiolipin and anti-β2-glycoprotein antibodies (anti-β2-GPI), lupus anticoagulant (LA), D-dimers, thrombin–antithrombin complexes (TAT), and von Willebrand factor (vWF). RESULTS: Multidetector computed tomography revealed coronary calcifications in 8 (30.8%) patients and the median CACS was 52.4 HU (range 2–843.2). The mean PWV was 9.0 ±3.2 m/s and was higher in patients aged > 50 years (+33.7% vs. < 50 years), those with positive LA (+28.2% vs. LA negative), TAT ≥ 10 μg/l (+18.1% vs. < 10 μg/l), vWF ≥ 200 IU/dl (+51.8% vs. < 200 IU/dl) and with coronary atherosclerosis (CACS > 0; +21.4% vs. CACS = 0). In contrast, the duration of the disease, D-dimers, anticardiolipin, and anti-β2-GPI antibodies did not influence PWV. In the group without atherosclerosis (CACS = 0, n =18), patients with vWF ≥ 200 IU/dl had a 19.3% higher PWV compared to the rest. CONCLUSIONS: In patients with SLE, PWV was associated with the presence of coronary atherosclerotic lesions in MDCT. Furthermore, arterial stiffness was higher in patients with markers of endothelial dysfunction and a prothrombotic state, suggesting their contribution to the early stages of arterial remodelling in SLE. Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2022-07-13 2022 /pmc/articles/PMC9301661/ /pubmed/35875719 http://dx.doi.org/10.5114/reum.2022.117836 Text en Copyright: © 2022 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Dziedzic-Oleksy, Hanna
Mazurek, Adam
Bugała, Kamil
Perricone, Carlo
Drabik, Leszek
Płazak, Wojciech
Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
title Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
title_full Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
title_fullStr Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
title_full_unstemmed Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
title_short Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
title_sort arterial stiffness and atherosclerosis in systemic lupus erythematosus patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301661/
https://www.ncbi.nlm.nih.gov/pubmed/35875719
http://dx.doi.org/10.5114/reum.2022.117836
work_keys_str_mv AT dziedzicoleksyhanna arterialstiffnessandatherosclerosisinsystemiclupuserythematosuspatients
AT mazurekadam arterialstiffnessandatherosclerosisinsystemiclupuserythematosuspatients
AT bugałakamil arterialstiffnessandatherosclerosisinsystemiclupuserythematosuspatients
AT perriconecarlo arterialstiffnessandatherosclerosisinsystemiclupuserythematosuspatients
AT drabikleszek arterialstiffnessandatherosclerosisinsystemiclupuserythematosuspatients
AT płazakwojciech arterialstiffnessandatherosclerosisinsystemiclupuserythematosuspatients